摘要
目的:系统评价沙参麦冬汤加减治疗慢性支气管炎(CB)的临床疗效及安全性。方法:计算机检索和筛选2015年6月前国内外电子数据库(5个中文和2个英文数据库)发表的符合纳入标准的相关文献,采用Cochrane系统评价员手册5.1版进行文献质量评价及其协作网提供的RevMan 5.3进行统计分析。结果:纳入11篇文献1169例CB患者(治疗组593例,对照组576例)。Meta分析结果显示,沙参麦冬汤能提高临床有效率,缩短患者的症状控制时间及住院时间。结论:单独或联合使用沙参麦冬汤加减治疗CB的临床疗效优于未使用沙参麦冬汤加减的西医常规治疗。
Objective： To systematically review and assess the efficacy and safety of Shashen Maidong Soup in the treatment of chronic bronchitis（ CB）. Methods： Comprehensive searches of 5 Chinese databases and 2 English databases were conducted up until July 2015 for all randomized controlled trials（ RCTs） on CB,evaluated with the Cochrane collaboration＇s bias risk assessment tool. The meta-analysis was conducted by Revman 5. 3. Results： A total of 11 RCTs involving 1169 participates（ treatment group： 593 participates; control group： 576 participates） were included. The results indicated that Shashen Maidong Soup could improve the clinical efficacy,shorten the duration of symptom of patients and the duraion of hospitalization. Conclusion： The results indicated that Shashen Maidong Soup were better than the western medication group without using Shashen Maidong Soup.
出处
《中国中医基础医学杂志》
CAS
CSCD
北大核心
2016年第6期821-824,共4页
JOURNAL OF BASIC CHINESE MEDICINE
